A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

Clinical trial NCT04796623 · COMPLETED

Trial details

NCT number: NCT04796623
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HR-positive, HER2-negative Advanced Breast Cancer

Start date: 2021-02-04
Primary completion: 2024-05-24
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.